- Home
- News
- canada quebec
- veterinary use
Veterinary Use Articles & Analysis
5 news found
The EU Active Substance Master File (ASMF) is a technical document containing confidential information on an API that is submitted by the manufacturer of the API to the EMA or the medicines regulatory authority of an EU member state. As a form of DMF in the EU, the ASMF is used to support MAA or MAV by manufacturers of pharmaceutical preparations for human or veterinary use. The ASMF applies to ...
Canadian biotechnology company ANGANY (www.ANGANY.com) is presenting its immunotherapy platform at BIO International Convention, a critical rendez-vous for the global pharmaceutical industry which takes place in San Diego, California between June 13th and 16th. ANGANY’s primary focus is the development of therapeutic vaccines, leveraging the unique immunogenicity and safety profile of its ...
EnGen Bio is an early stage biotechnology company developing a new approach to preventing and treating all Type A influenza strains—including all flu pandemics. Seasonal flu causes 50,000–250,000 deaths worldwide annually, causing the World Health Organization to declare the development of a universal flu vaccine as an urgent need in its Global Influenza Strategy (2019–2030) ...
A University of Wyoming spin-out business has received a $150,000 Small Business Innovation Research (SBIR) grant to improve the effectiveness of drugs that can potentially help diabetes and cancer patients. GlycoBac will use the six-month grant from the National Institutes of Health (NIH) for research to improve the effectiveness of already developed glycoprotein drugs. The overall ...
The National Food Institute, part of the Technical University of Denmark, and LEI Wageningen UR made an analysis of the antibiotic use in pigs in Denmark and The Netherlands. The analysis shows that in 2012, The Netherlands used approximately 20% less antibiotics in pigs than Denmark. For several years now, Denmark is known for its low veterinary antibiotic use. However, the overall average ...
